ClinicalTrials.gov record
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
ClinicalTrials.gov ID: NCT01576718
Public ClinicalTrials.gov record NCT01576718. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week Dose-ranging Study to Evaluate the Efficacy and Safety of Fp Spiromax® (Fluticasone Propionate Inhalation Powder) Administered Twice Daily Compared With Placebo in Adolescent and Adult Subjects With Severe Persistent Asthma Uncontrolled on High Dose Inhaled Corticosteroid Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the dose response, efficacy and safety of 4 different doses of fluticasone propionate (50, 100, 200, and 400mcg) delivered as Fluticasone Spiromax® Inhalation Powder (Fp Spiromax) when administered twice daily in subjects 12 years of age and older with severe persistent asthma who are uncontrolled on high dose ICS therapy.
Study identification
- NCT ID
- NCT01576718
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 889 participants
Conditions and interventions
Conditions
Interventions
- Fp MDPI Drug
- Placebo MDPI Other
- Flovent Diskus Drug
- albuterol/salbutamol Drug
Drug · Other
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2012 (Type not available)
- Primary completion
- Jul 2013 (Actual)
- Completion
- Oct 2013 (Actual)
- Last update posted
- May 8, 2018
2012 – 2013
United States locations
- U.S. sites
- 148
- U.S. states
- 35
- U.S. cities
- 117
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 10504 | Birmingham | Alabama | — | — |
| Teva Investigational Site 10565 | Homewood | Alabama | — | — |
| Teva Investigational Site 11527 | Goodyear | Arizona | — | — |
| Teva Investigational Site 10516 | Tucson | Arizona | — | — |
| Teva Investigational Site 10573 | Bakersfield | California | — | — |
| Teva Investigational Site 11518 | Costa Mesa | California | — | — |
| Teva Investigational Site 10590 | Fountain Valley | California | — | — |
| Teva Investigational Site 10551 | Granada Hills | California | — | — |
| Teva Investigational Site 11520 | Huntington Beach | California | — | — |
| Teva Investigational Site 11545 | Huntington Beach | California | — | — |
| Teva Investigational Site 10547 | Long Beach | California | — | — |
| Teva Investigational Site 11549 | Los Angeles | California | — | — |
| Teva Investigational Site 10503 | Mission Viejo | California | — | — |
| Teva Investigational Site 10536 | Newport Beach | California | — | — |
| Teva Investigational Site 10540 | Orange | California | — | — |
| Teva Investigational Site 11551 | Orange | California | — | — |
| Teva Investigational Site 10578 | Palmdale | California | — | — |
| Teva Investigational Site 10585 | Redwood City | California | — | — |
| Teva Investigational Site 11538 | Rolling Hills Estates | California | — | — |
| Teva Investigational Site 11522 | Roseville | California | — | — |
| Teva Investigational Site 10582 | San Diego | California | — | — |
| Teva Investigational Site 11554 | San Diego | California | — | — |
| Teva Investigational Site 10563 | San Jose | California | — | — |
| Teva Investigational Site 11556 | Santa Monica | California | — | — |
| Teva Investigational Site 10506 | Stockton | California | — | — |
| Teva Investigational Site 10529 | Walnut Creek | California | — | — |
| Teva Investigational Site 10545 | Centennial | Colorado | — | — |
| Teva Investigational Site 10572 | Colorado Springs | Colorado | — | — |
| Teva Investigational Site 10533 | Denver | Colorado | — | — |
| Teva Investigational Site 11531 | Denver | Colorado | — | — |
| Teva Investigational Site 11542 | Denver | Colorado | — | — |
| Teva Investigational Site 11569 | Wheat Ridge | Colorado | — | — |
| Teva Investigational Site 10528 | Waterbury | Connecticut | — | — |
| Teva Investigational Site 10556 | Boynton Beach | Florida | — | — |
| Teva Investigational Site 11513 | Brandon | Florida | — | — |
| Teva Investigational Site 11507 | Clearwater | Florida | — | — |
| Teva Investigational Site 11546 | Fort Myers | Florida | — | — |
| Teva Investigational Site 11526 | Hialeah | Florida | — | — |
| Teva Investigational Site 11525 | Kissimmee | Florida | — | — |
| Teva Investigational Site 10537 | Miami | Florida | — | — |
| Teva Investigational Site 10553 | Miami | Florida | — | — |
| Teva Investigational Site 11508 | Miami | Florida | — | — |
| Teva Investigational Site 11514 | Miami | Florida | — | — |
| Teva Investigational Site 11516 | Miami | Florida | — | — |
| Teva Investigational Site 11530 | Miami | Florida | — | — |
| Teva Investigational Site 11570 | Miami | Florida | — | — |
| Teva Investigational Site 10571 | Ocala | Florida | — | — |
| Teva Investigational Site 11537 | Sarasota | Florida | — | — |
| Teva Investigational Site 10593 | South Miami | Florida | — | — |
| Teva Investigational Site 11555 | Tallahassee | Florida | — | — |
| Teva Investigational Site 10554 | Tamarac | Florida | — | — |
| Teva Investigational Site 10539 | Tampa | Florida | — | — |
| Teva Investigational Site 10525 | Valrico | Florida | — | — |
| Teva Investigational Site 11504 | Albany | Georgia | — | — |
| Teva Investigational Site 10511 | Columbus | Georgia | — | — |
| Teva Investigational Site 11510 | Columbus | Georgia | — | — |
| Teva Investigational Site 11572 | Columbus | Georgia | — | — |
| Teva Investigational Site 10568 | Lawrenceville | Georgia | — | — |
| Teva Investigational Site 10586 | Lilburn | Georgia | — | — |
| Teva Investigational Site 11539 | Savannah | Georgia | — | — |
| Teva Investigational Site 10543 | Stockbridge | Georgia | — | — |
| Teva Investigational Site 11558 | Indianapolis | Indiana | — | — |
| Teva Investigational Site 10527 | South Bend | Indiana | — | — |
| Teva Investigational Site 10584 | Iowa City | Iowa | — | — |
| Teva Investigational Site 11501 | Overland Park | Kansas | — | — |
| Teva Investigational Site 10591 | Lexington | Kentucky | — | — |
| Teva Investigational Site 11567 | Louisville | Kentucky | — | — |
| Teva Investigational Site 10513 | Metairie | Louisiana | — | — |
| Teva Investigational Site 10564 | Bangor | Maine | — | — |
| Teva Investigational Site 11548 | Baltimore | Maryland | — | — |
| Teva Investigational Site 10510 | Largo | Maryland | — | — |
| Teva Investigational Site 10577 | Wheaton | Maryland | — | — |
| Teva Investigational Site 10538 | Brockton | Massachusetts | — | — |
| Teva Investigational Site 10546 | North Dartmouth | Massachusetts | — | — |
| Teva Investigational Site 11502 | Troy | Michigan | — | — |
| Teva Investigational Site 10531 | Plymouth | Minnesota | — | — |
| Teva Investigational Site 11562 | Columbia | Missouri | — | — |
| Teva Investigational Site 11563 | Columbia | Missouri | — | — |
| Teva Investigational Site 10552 | St Louis | Missouri | — | — |
| Teva Investigational Site 10575 | St Louis | Missouri | — | — |
| Teva Investigational Site 10589 | St Louis | Missouri | — | — |
| Teva Investigational Site 11532 | St Louis | Missouri | — | — |
| Teva Investigational Site 10518 | Bellevue | Nebraska | — | — |
| Teva Investigational Site 10550 | Omaha | Nebraska | — | — |
| Teva Investigational Site 11529 | Omaha | Nebraska | — | — |
| Teva Investigational Site 11571 | Las Vegas | Nevada | — | — |
| Teva Investigational Site 10559 | Cherry Hill | New Jersey | — | — |
| Teva Investigational Site 11566 | Edison | New Jersey | — | — |
| Teva Investigational Site 10501 | Hillsborough | New Jersey | — | — |
| Teva Investigational Site 11550 | Ocean City | New Jersey | — | — |
| Teva Investigational Site 10588 | West Orange | New Jersey | — | — |
| Teva Investigational Site 11503 | Albuquerque | New Mexico | — | — |
| Teva Investigational Site 10587 | Brooklyn | New York | — | — |
| Teva Investigational Site 10520 | New York | New York | — | — |
| Teva Investigational Site 10532 | Newburgh | New York | — | — |
| Teva Investigational Site 10567 | North Syracuse | New York | — | — |
| Teva Investigational Site 10512 | Rochester | New York | — | — |
| Teva Investigational Site 10580 | The Bronx | New York | — | — |
| Teva Investigational Site 10522 | Canton | Ohio | — | — |
| Teva Investigational Site 10507 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 10523 | Cincinnati | Ohio | — | — |
| Teva Investigational Site 10544 | Columbus | Ohio | — | — |
| Teva Investigational Site 11521 | Dayton | Ohio | — | — |
| Teva Investigational Site 11505 | Middleburg Heights | Ohio | — | — |
| Teva Investigational Site 10560 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 10574 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 10579 | Oklahoma City | Oklahoma | — | — |
| Teva Investigational Site 11544 | Tulsa | Oklahoma | — | — |
| Teva Investigational Site 10598 | Ashland | Oregon | — | — |
| Teva Investigational Site 11543 | Medford | Oregon | — | — |
| Teva Investigational Site 11557 | Portland | Oregon | — | — |
| Teva Investigational Site 10509 | Altoona | Pennsylvania | — | — |
| Teva Investigational Site 10555 | Philadelphia | Pennsylvania | — | — |
| Teva Investigational Site 10566 | Pittsburgh | Pennsylvania | — | — |
| Teva Investigational Site 10521 | Upland | Pennsylvania | — | — |
| Teva Investigational Site 10581 | Lincoln | Rhode Island | — | — |
| Teva Investigational Site 10562 | Providence | Rhode Island | — | — |
| Teva Investigational Site 10526 | Charleston | South Carolina | — | — |
| Teva Investigational Site 11547 | Charleston | South Carolina | — | — |
| Teva Investigational Site 10583 | Orangeburg | South Carolina | — | — |
| Teva Investigational Site 10517 | Spartanburg | South Carolina | — | — |
| Teva Investigational Site 11515 | Spartanburg | South Carolina | — | — |
| Teva Investigational Site 10519 | Boerne | Texas | — | — |
| Teva Investigational Site 10541 | Dallas | Texas | — | — |
| Teva Investigational Site 10542 | Dallas | Texas | — | — |
| Teva Investigational Site 10548 | El Paso | Texas | — | — |
| Teva Investigational Site 11552 | El Paso | Texas | — | — |
| Teva Investigational Site 11512 | Fort Worth | Texas | — | — |
| Teva Investigational Site 11565 | Houston | Texas | — | — |
| Teva Investigational Site 11568 | Houston | Texas | — | — |
| Teva Investigational Site 10515 | San Antonio | Texas | — | — |
| Teva Investigational Site 10569 | San Antonio | Texas | — | — |
| Teva Investigational Site 11517 | San Antonio | Texas | — | — |
| Teva Investigational Site 11519 | San Antonio | Texas | — | — |
| Teva Investigational Site 11560 | Waco | Texas | — | — |
| Teva Investigational Site 11528 | Layton | Utah | — | — |
| Teva Investigational Site 10576 | Provo | Utah | — | — |
| Teva Investigational Site 10534 | South Burlington | Vermont | — | — |
| Teva Investigational Site 10502 | Fairfax | Virginia | — | — |
| Teva Investigational Site 10595 | Manassas | Virginia | — | — |
| Teva Investigational Site 10508 | Richmond | Virginia | — | — |
| Teva Investigational Site 11561 | Bellingham | Washington | — | — |
| Teva Investigational Site 11541 | Seattle | Washington | — | — |
| Teva Investigational Site 10524 | Spokane | Washington | — | — |
| Teva Investigational Site 10530 | Tacoma | Washington | — | — |
| Teva Investigational Site 11511 | Tacoma | Washington | — | — |
| Teva Investigational Site 10570 | Greenfield | Wisconsin | — | — |
| Teva Investigational Site 11559 | Greenfield | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 152 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01576718, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 8, 2018 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01576718 live on ClinicalTrials.gov.